BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27238937)

  • 1. Pathways Regulating the pbgP Operon and Colistin Resistance in Klebsiella pneumoniae Strains.
    Choi MJ; Kim S; Ko KS
    J Microbiol Biotechnol; 2016 Sep; 26(9):1620-8. PubMed ID: 27238937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae.
    Kim SJ; Ko KS
    Int J Antimicrob Agents; 2018 Sep; 52(3):425-429. PubMed ID: 29944953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains.
    Choi MJ; Ko KS
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6763-73. PubMed ID: 26282408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India.
    Kumar A; Biswas L; Omgy N; Mohan K; Vinod V; Sajeev A; Nair P; Singh S; Biswas R
    Rev Esp Quimioter; 2018 Oct; 31(5):406-410. PubMed ID: 30221899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
    Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.
    Wright MS; Suzuki Y; Jones MB; Marshall SH; Rudin SD; van Duin D; Kaye K; Jacobs MR; Bonomo RA; Adams MD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):536-43. PubMed ID: 25385117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in two component system (PhoPQ and PmrAB) in colistin resistant Klebsiella pneumoniae from North Indian tertiary care hospital.
    Nirwan PK; Chatterjee N; Panwar R; Dudeja M; Jaggi N
    J Antibiot (Tokyo); 2021 Jul; 74(7):450-457. PubMed ID: 33820943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
    Cannatelli A; D'Andrea MM; Giani T; Di Pilato V; Arena F; Ambretti S; Gaibani P; Rossolini GM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5521-6. PubMed ID: 23979739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258.
    Kocsis B; Kádár B; Tóth Á; Fullár A; Szabó D
    J Microbiol Immunol Infect; 2017 Oct; 50(5):735-736. PubMed ID: 27553451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in Klebsiella pneumoniae.
    Cheng YH; Lin TL; Lin YT; Wang JT
    J Antimicrob Chemother; 2018 Jun; 73(6):1509-1516. PubMed ID: 29506266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms of Colistin Resistance Among Klebsiella Pneumoniae Strains.
    Borsa BA; Demirci M; Gungordu-Dalar Z; Karabiyik G; Aygun G; Kucukbasmaci O
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.
    Jayol A; Poirel L; Brink A; Villegas MV; Yilmaz M; Nordmann P
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4762-6. PubMed ID: 24914122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of colistin-resistant populations prior to antibiotic exposure in KPC-2-producing Klebsiella pneumoniae clinical isolates.
    Seo J; Wi YM; Kim JM; Kim YJ; Ko KS
    J Microbiol; 2021 Jun; 59(6):590-597. PubMed ID: 33779958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of colistin-resistant Enterobacteriaceae in inpatient and avian isolates from China: high prevalence of mcr-negative Klebsiella pneumoniae.
    Wang X; Liu Y; Qi X; Wang R; Jin L; Zhao M; Zhang Y; Wang Q; Chen H; Wang H
    Int J Antimicrob Agents; 2017 Oct; 50(4):536-541. PubMed ID: 28668693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
    Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
    J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital.
    Jaidane N; Bonnin RA; Mansour W; Girlich D; Creton E; Cotellon G; Chaouch C; Boujaafar N; Bouallegue O; Naas T
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29229634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Detection of Colistin-Resistant
    Nawfal Dagher T; Azar E; Al-Bayssari C; Chamieh AS; Rolain JM
    Microb Drug Resist; 2019; 25(6):925-930. PubMed ID: 30883263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.
    Cannatelli A; Di Pilato V; Giani T; Arena F; Ambretti S; Gaibani P; D'Andrea MM; Rossolini GM
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4399-403. PubMed ID: 24841267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of colistin resistance in
    Chen X; Sun Z; Xu X; Jiang J; Su J
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.